春立医疗股价涨5.15%

Core Viewpoint - Spring Medical has seen a significant stock price increase of 9.18% over the past three days, indicating strong market interest and potential growth in the orthopedic medical device sector [1] Company Overview - Beijing Spring Medical Co., Ltd. specializes in the research, production, and sales of implantable orthopedic medical devices, with a focus on joint prosthetics and spinal implants [1] - The company was established on February 12, 1998, and went public on December 30, 2021 [1] - Its main products include hip, knee, shoulder, and elbow joint prosthetics, as well as a full range of spinal fixation systems [1] - The company exports its products to various regions, including Asia, South America, Africa, Oceania, and Europe [1] - The revenue composition is primarily from medical device products (99.89%) with a minor contribution from other sources (0.11%) [1] Shareholder Information - Southern Fund's Southern Medical Health Flexible Allocation Mixed A Fund (000452) is among the top ten circulating shareholders of Spring Medical, holding 1.603 million shares, which is 0.42% of the circulating shares [2] - The fund has realized a floating profit of approximately 2.0518 million yuan today and 3.3503 million yuan during the three-day price increase [2] - The fund was established on January 23, 2014, and has a current scale of 2.405 billion yuan, with a year-to-date return of 43.87% [2] Fund Management - The fund manager of Southern Medical Health Flexible Allocation Mixed A is Cai Qiang, who has been in the position for 2 years and 128 days [3] - The total asset size of the fund is 4.213 billion yuan, with the best return during his tenure being 21.06% and the worst being 0% [3]